Ras-transfection Up-regulated HaCaT Cell Migration: Inhibition by Marimastat

Overview

Journal Clin Exp Metastasis

Specialty Oncology

Date 2000 Aug 5

PMID 10919713

Citations 6

Authors

S Charvat

C Le Griel

M C Chignol

D Schmitt

M Serres

Affiliations

Soon will be listed here.

Abstract

Cell migration is an essential process in physiological and pathological conditions such as wound healing and tumor invasion. This phenomenon involves cell adhesion on the extracellular matrix mediated by integrins, and cell detachment promoted in part by metalloproteinases (MMPs). In the present study, the migration of two HaCaT-ras clones (metastatic or not), was compared with HaCaT cells, and normal human primary cultured keratinocytes. Using colloidal gold migration assay, the migration index on type I and type IV collagen was similar for primary cultured keratinocytes and HaCaT, whereas it was markedly higher for the HaCaT-ras clones. High motility of ras-transfected cells was confirmed from an in vitro wound healing assay. It was not correlated with changes in integrin expression or related to a different adhesion on extracellular matrix. The Marismastat (BB-2516), a MMP inhibitor, inhibited in a dose-dependent effect the migration in both assays, demonstrating the important role of MMPs in the migration process. Under our experimental conditions, MMP-1 activity was not detected in HaCaT and MMP-9 activity was secreted by these cells only after their stimulation by EGF. Here, MMP-2 was the major gelatinolytic activity secreted by all the cells and its secretion was markedly higher for HaCaT-nis clones compared with HaCaT. In addition, Western blotting results confirmed a higher expression of MMP-2 associated with a lower expression of TIMP-2 in HaCaT-ras compared with HaCaT. These results suggest that Ha-ras oncogene could be a stimulating factor of migration and might modified the balance between MMP-2 and TIMP-2 in keratinocyte cell lines.

Citing Articles

Matrix metalloproteinase (MMP)-degradable tissue engineered periosteum coordinates allograft healing via early stage recruitment and support of host neurovasculature.

Li Y, Hoffman M, Benoit D Biomaterials. 2020; 268:120535.

PMID: 33271450 PMC: 8110201. DOI: 10.1016/j.biomaterials.2020.120535.

Comparative transcriptomic profiling of hydrogen peroxide signaling networks in zebrafish and human keratinocytes: Implications toward conservation, migration and wound healing.

Lisse T, King B, Rieger S Sci Rep. 2016; 6:20328.

PMID: 26846883 PMC: 4742856. DOI: 10.1038/srep20328.

Menadione : sodium orthovanadate combination eliminates and inhibits migration of detached cancer cells.

Delwar Z, Siden A, Cruz M, Yakisich J ISRN Pharmacol. 2012; 2012:307102.

PMID: 22957270 PMC: 3431120. DOI: 10.5402/2012/307102.

Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration.

Yadav V, Denning M Mol Carcinog. 2011; 50(5):346-52.

PMID: 21480388 PMC: 3080437. DOI: 10.1002/mc.20716.

Comparative studies on the secretion and activation of MMPs in two reconstructed human skin models using HaCaT- and HaCaT-ras-transfected cell lines.

Nova D, Le Griel C, Holvoet S, Gentilhomme E, Vincent C, Staquet M Clin Exp Metastasis. 2004; 20(8):675-83.

PMID: 14713102 DOI: 10.1023/b:clin.0000006816.09548.31.

References

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Inoue M, Kratz G, Haegerstrand A . Collagenase expression is rapidly induced in wound-edge keratinocytes after acute injury in human skin, persists during healing, and stops at re-epithelialization. J Invest Dermatol. 1995; 104(4):479-83. DOI: 10.1111/1523-1747.ep12605917. View

Sudbeck B, Pilcher B, Welgus H, Parks W . Induction and repression of collagenase-1 by keratinocytes is controlled by distinct components of different extracellular matrix compartments. J Biol Chem. 1997; 272(35):22103-10. DOI: 10.1074/jbc.272.35.22103. View

. The phagokinetic tracks of 3T3 cells. Cell. 1977; 11(2):395-404. DOI: 10.1016/0092-8674(77)90057-5. View

Tang B, Hong W . ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. FEBS Lett. 1999; 445(2-3):223-5. DOI: 10.1016/s0014-5793(99)00119-2. View

Thant A, Serbulea M, Kikkawa F, Liu E, Tomoda Y, Hamaguchi M . c-Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells. FEBS Lett. 1997; 406(1-2):28-30. DOI: 10.1016/s0014-5793(97)00230-5. View

Petersen M, Woodley D, Stricklin G, Okeefe E . Constitutive production of procollagenase and tissue inhibitor of metalloproteinases by human keratinocytes in culture. J Invest Dermatol. 1989; 92(2):156-9. DOI: 10.1111/1523-1747.ep12276678. View

Sudbeck B, Pilcher B, Pentland A, Parks W . Modulation of intracellular calcium levels inhibits secretion of collagenase 1 by migrating keratinocytes. Mol Biol Cell. 1997; 8(5):811-24. PMC: 276131. DOI: 10.1091/mbc.8.5.811. View

Breitkreutz D, Boukamp P, Ryle C, Stark H, Roop D, Fusenig N . Epidermal morphogenesis and keratin expression in c-Ha-ras-transfected tumorigenic clones of the human HaCaT cell line. Cancer Res. 1991; 51(16):4402-9. View

10.

Pilcher B, Dumin J, Sudbeck B, Krane S, Welgus H, Parks W . The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol. 1997; 137(6):1445-57. PMC: 2132537. DOI: 10.1083/jcb.137.6.1445. View

11.

Curran S, Murray G . Matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 1999; 189(3):300-8. DOI: 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C. View

12.

Collier I, Wilhelm S, Eisen A, Marmer B, Grant G, Seltzer J . H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem. 1988; 263(14):6579-87. View

13.

Bramhall S . The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application. Int J Pancreatol. 1997; 21(1):1-12. DOI: 10.1007/BF02785914. View

14.

Boukamp P, Peter W, Pascheberg U, Altmeier S, Fasching C, Stanbridge E . Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and additional chromosome loss. Oncogene. 1995; 11(5):961-9. View

15.

Kobayashi T, Hattori S, Nagai Y, Tajima S, Nishikawa T . Differential regulation of MMP-2 and MMP-9 gelatinases in cultured human keratinocytes. Dermatology. 1998; 197(1):1-5. DOI: 10.1159/000017967. View

16.

Brown P . Matrix metalloproteinase inhibitors in the treatment of cancer. Med Oncol. 1997; 14(1):1-10. DOI: 10.1007/BF02990939. View

17.

Rasmussen H, McCann P . Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol Ther. 1997; 75(1):69-75. DOI: 10.1016/s0163-7258(97)00023-5. View

18.

Fradet Y, Cordon-Cardo C, Thomson T, Daly M, WHITMORE Jr W, LLOYD K . Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1984; 81(1):224-8. PMC: 344644. DOI: 10.1073/pnas.81.1.224. View

19.

Greig R, Koestler T, Trainer D, Corwin S, Miles L, Kline T . Tumorigenic and metastatic properties of "normal" and ras-transfected NIH/3T3 cells. Proc Natl Acad Sci U S A. 1985; 82(11):3698-701. PMC: 397854. DOI: 10.1073/pnas.82.11.3698. View

20.

Petersen M, Woodley D, Stricklin G, Okeefe E . Enhanced synthesis of collagenase by human keratinocytes cultured on type I or type IV collagen. J Invest Dermatol. 1990; 94(3):341-6. DOI: 10.1111/1523-1747.ep12874471. View